PACS vs. NHC, ENSG, RDNT, IOVA, ITGR, BHVN, AXSM, INSM, SMMT, and PBH
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include National HealthCare (NHC), The Ensign Group (ENSG), RadNet (RDNT), Iovance Biotherapeutics (IOVA), Integer (ITGR), Biohaven (BHVN), Axsome Therapeutics (AXSM), Insmed (INSM), Summit Therapeutics (SMMT), and Prestige Consumer Healthcare (PBH). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and National HealthCare (NYSE:NHC) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.
National HealthCare has higher revenue and earnings than PACS Group.
56.4% of National HealthCare shares are held by institutional investors. 13.8% of National HealthCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, PACS Group had 25 more articles in the media than National HealthCare. MarketBeat recorded 27 mentions for PACS Group and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 0.33 beat PACS Group's score of 0.26 indicating that National HealthCare is being referred to more favorably in the news media.
National HealthCare has a net margin of 6.95% compared to PACS Group's net margin of 0.00%. National HealthCare's return on equity of 6.28% beat PACS Group's return on equity.
PACS Group presently has a consensus target price of $31.00, indicating a potential upside of 9.89%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than National HealthCare.
PACS Group received 10 more outperform votes than National HealthCare when rated by MarketBeat users.
Summary
National HealthCare beats PACS Group on 7 of the 11 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
PACS Group Competitors List
Related Companies and Tools